Stora Enso will build a pilot facility for producing Cellufoam™ by Stora Enso, a lightweight, fiber-based foam material for protective packaging and cushioning. Bio-based foams are renewable and recyclable and can be used in packaging, for example, to replace oil-based polymer foams which are widely used today. The pilot plant will be located at Stora Enso’s Fors Mill in Sweden.
“100% Bioplastic”. It’s the name of the research project launched by Bicocca University of Crowdfunding to develop a new material of natural and biodegradable origin. The fundraising is starting today on Produzioni dal Basso with the support of Corepla, the Italian Consortiun of Recycled Plastics.
Amyris, a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully scaled up the commercial production of Cannabigerol (CBG) leveraging its industrial fermentation process capability.
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, launched Dyneema, which is driving the performance of Team Sunweb’s protective cycling jerseys in the 2020 Tour de France. Together with its partners, Team Sunweb and Craft Sportswear, DSM has helped to deliver a jersey that, when combined with a protective baselayer, offers cyclists effective abrasion protection at speeds up to 60kph, while also reducing the severity of open wounds at even higher speeds. In this way, DSM underlines its commitment to protect people and the environment they live in.
According to the UNEP1, the fashion industry makes up for 10% of global greenhouse gas emissions – more than international flights and shipping combined. TOMS – short for Tomorrow’s Shoes – has committed to reduce its carbon footprint by 2025, and this already starts with the choice of resources and materials for production.
Switzerland’s largest retail company, Migros, and its subsidiary, Mibelle Group, have launched a new range of cleaning products, containing LanzaTech ethanol made from recycled pollution. The Beijing Shougang LanzaTech New Energy Science & Technology Co., Ltd. a joint venture between carbon recycler, LanzaTech, Shougang Group, a leading Chinese iron and steel producer, Shougang FUND, DEHUI group and its New Zealand partner, TangMing, has been producing ethanol from recycled steel mill emissions in China, since 2018. Over 80 Tons of this ethanol, has been shipped to Europe and used in the Migros Plus Oeko Power and Potz cleaning ranges in Mibelle Group’s portfolio. These products are now on sale in Migros supermarkets in Switzerland.
Clariant’s Business Line Biofuels and Derivatives announced on August 15 during a joint presentation at the 7thAsia-Pacific Biomass Utilization Summit in Guangzhou that a strategic partnership has been formed with Chemtex Global Corporation for the realization of second-generation biofuel projects. Under the partnership, the two parties will collaborate to market and sell Clariant’s sunliquid®technology licenses, as well as services and supplies for advanced biofuel plants in China.
Rome is the world capital of the bioeconomy. The International Forum on Industrial Biotechnology and Bioeconomy (IFIB) will be held in the Eternal City this year at the WeGil Congress Center. And in this Covid-19 era, it will be both physical and digital.
With more than 300 delegates in attendance from approximately 25 different countries from all around the world (only 100 will be hosted at the Congress Center, the other attendants could follow the forum through Webex Cisco), the conference truly succeeds one more time in its ambitions aim to be one of the leading bioeconomy event at global level. Continue reading
Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets and IDRI (Infectious Disease Research Institute) signed a binding term sheet for a planned COVID-19 RNA (ribonucleic acid) vaccine technology program. The program combines IDRI’s expertise in combating infectious diseases with Amyris’ fermentation platform technology, with the goal to create semi-synthetic squalene-based adjuvants at scale.
“At Union level, the European Green Deal is surely a clear and strong signal to many industries, and this will help our clients to gain further competing edges vs parties that still struggle to understand the benefit of implementing biosynthesis into their processes as tool to increase their competitiveness and sustainability.” To say it – in this exclusive interview with Il Bioeconomista – is Cyrille Pauthenier, Ceo and co-founder of Abolis, an industrial biotech company located in France. Pauthenier is graduated from École Normale Supérieure de Paris where he studied fundamental chemistry and biology. In 2011, he specialized in synthetic biology. In 2014, after obtaining his Ph.D., Cyrille co-founded Abolis, with the aim of using biology to accelerate the ecological transition of chemical industry.
Interview by Mario Bonaccorso
IL BIOECONOMISTA 